Role of ozone therapy in preventing testicular damage in an experimental cryptorchid rat model
Özet
Background: Cryptorchidism is the most common developmental abnormality of the male reproductive system. If left untreated, it results with infertility and testicular cancer. According to current evidence, surgery is the mainstay of treatment, and hormonal therapy approaches are still under investigation. For the protection of testicular functions, antioxidants have emerged as novel options. This study aimed to evaluate the protective properties of ozone, a strong antioxidant, on testicular tissue. Material/Methods: Thirty-five male Wistar-albino rats, 1-month-old, were used for the study. Groups were formed as follows: 1) control, 2) sham surgery (cryptorchidism), 3) cryptorchidism plus ozone, 4) cryptorchidism plus human chorionic gonadotropin (hCG), and 5) ozone plus hCG. Surgical procedures were performed on all rats except the control group. All rats except the control group were used to create an experimental cryptorchidism model, and left testes of animals were surgically placed into the abdomen. After 1 month of surgery, groups 3, 4, and 5 were given corresponding treatments intraperitoneally for 4 weeks. At the end of the study period, testicular atrophy index (TAI) and testicular sperm motility (TSM) were assessed and biochemical, histopathological, and immunohistochemical tests were performed. Results: TAI and TSM were higher in the ozone, hCG, and ozone plus hCG groups than in the sham surgery group (p=0.001). TSM in the ozone group was significantly higher than in the hCG and ozone plus hCG groups. In biochemical analyses, the parameters of oxidative stress (GPx1, MDA, CAT, GSH, SOD) indicated increased oxidative activity in cryptorchidism, which was resolved by applying ozone and hCG (p=0.001). In addition, apoptotic markers, Caspase 3 and bcl-2 were significantly decreased by applying ozone and hCG (p=0.001). Conclusions: Results of this study suggest that ozone therapy, either as a single agent or in combination with hCG, is a promising approach for protection of testicular functions. © Med Sci Monit.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Biçer, Şenol | |
| dc.contributor.author | Gürsul, Cebrail | |
| dc.contributor.author | Sayar, İlyas | |
| dc.contributor.author | Akman, Orhan | |
| dc.contributor.author | Çakarlı, Seçil | |
| dc.contributor.author | Aydın, Merve | |
| dc.date.accessioned | 2026-10-18T20:28:54.651888424Z | |
| dc.date.available | 2026-10-18T20:28:54.651888424Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Background: Cryptorchidism is the most common developmental abnormality of the male reproductive system. If left untreated, it results with infertility and testicular cancer. According to current evidence, surgery is the mainstay of treatment, and hormonal therapy approaches are still under investigation. For the protection of testicular functions, antioxidants have emerged as novel options. This study aimed to evaluate the protective properties of ozone, a strong antioxidant, on testicular tissue. Material/Methods: Thirty-five male Wistar-albino rats, 1-month-old, were used for the study. Groups were formed as follows: 1) control, 2) sham surgery (cryptorchidism), 3) cryptorchidism plus ozone, 4) cryptorchidism plus human chorionic gonadotropin (hCG), and 5) ozone plus hCG. Surgical procedures were performed on all rats except the control group. All rats except the control group were used to create an experimental cryptorchidism model, and left testes of animals were surgically placed into the abdomen. After 1 month of surgery, groups 3, 4, and 5 were given corresponding treatments intraperitoneally for 4 weeks. At the end of the study period, testicular atrophy index (TAI) and testicular sperm motility (TSM) were assessed and biochemical, histopathological, and immunohistochemical tests were performed. Results: TAI and TSM were higher in the ozone, hCG, and ozone plus hCG groups than in the sham surgery group (p=0.001). TSM in the ozone group was significantly higher than in the hCG and ozone plus hCG groups. In biochemical analyses, the parameters of oxidative stress (GPx1, MDA, CAT, GSH, SOD) indicated increased oxidative activity in cryptorchidism, which was resolved by applying ozone and hCG (p=0.001). In addition, apoptotic markers, Caspase 3 and bcl-2 were significantly decreased by applying ozone and hCG (p=0.001). Conclusions: Results of this study suggest that ozone therapy, either as a single agent or in combination with hCG, is a promising approach for protection of testicular functions. © Med Sci Monit. | |
| dc.description.sponsorship | Funding text 1: was evaluated by biochemical assays, including MDA, SOD, CAT, GSH, and GPx1. Apoptotic changes were evaluated by Bcl-2 and Caspase-3, and immunohistochemical evaluations included Caspase-3 staining. The Ethics Committee for Animal Experiments of the University of Atatürk, Erzurum, Turkey approved this study (05.06.2015-129). This research was supported by Erzincan University Unit of Scientific Projects (2015), Erzincan, Turkey.; Funding text 2: Şenol Biçer, e-mail: drsenolbicer@gmail.com This research was supported by Erzincan University Unit of Scientific Projects (2015, SAG-A-080715-0161), Erzincan, Turkey; Funding text 3: This research was supported by Erzincan University Unit of Scientific Projects (2015, SAG-A-080715-0161), Erzincan, Turkey | |
| dc.identifier.doi | 10.12659/msm.910459 | |
| dc.identifier.endpage | 5839 | |
| dc.identifier.issn | 1234-1010 | |
| dc.identifier.pmcid | PMC6113856 | |
| dc.identifier.pmid | 30130360 | |
| dc.identifier.scopus | 2-s2.0-85053683272 | |
| dc.identifier.startpage | 5832 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14130 | |
| dc.identifier.volume | 24 | |
| dc.identifier.wos | WOS:000442288500003 | |
| dc.language.iso | en | |
| dc.publisher | International Scientific Information, Inc. | |
| dc.relation.ispartof | Medical Science Monitor | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Antioxidants | |
| dc.subject | Beta subunit | |
| dc.subject | Chorionic gonadotropin | |
| dc.subject | Cryptorchidism | |
| dc.subject | Fertility | |
| dc.subject | Human | |
| dc.subject | Ozone | |
| dc.subject | Animals | |
| dc.subject | Disease Models, Animal | |
| dc.subject | Gonadotropins | |
| dc.subject | Male | |
| dc.subject | Rats | |
| dc.subject | Rats, Wistar | |
| dc.subject | Sperm Motility | |
| dc.subject | Testis | |
| dc.subject | Testosterone | |
| dc.subject | antioxidant | |
| dc.subject | caspase 3 | |
| dc.subject | catalase | |
| dc.subject | glutathione | |
| dc.subject | glutathione peroxidase 1 | |
| dc.subject | malonaldehyde | |
| dc.subject | protein bcl 2 | |
| dc.subject | superoxide dismutase | |
| dc.subject | gonadotropin | |
| dc.subject | animal experiment | |
| dc.subject | animal model | |
| dc.subject | animal tissue | |
| dc.subject | Article | |
| dc.subject | biochemical analysis | |
| dc.title | Role of ozone therapy in preventing testicular damage in an experimental cryptorchid rat model | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 3 | |
| rdl.citation.wos | 3 | |
| rdl.department | Department of Pediatric Surgery, Medical School of Erzincan University, Erzincan, Turkey. | Department of Physiology, Medical School of Erzincan University, Erzincan, Turkey. | Department of Pathology, Medical School of Erzincan University, Erzincan, Turkey. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
